[Probesci strategy: a cheaper therapeutic approach for obese patients].
Obesity has become epidemic in Western countries. From clinical practice, obestity may be considered as a disease characterized by an excess of body fat mass, but patients usually demonstrate different responses to the same therapeutic strategy. It could be possible that the latter may be a consecuence of different pathophysiological factors among obese patients. Therefore, a detailed and thorough phenotyping of patients may enable clinitians to establish groups of patients that may respond in a homogeneous and effective way to a specific treatment for obesity. However, this type of approach can be especially time-consuming and may increase costs. In this study we describe the "PROBESCI" strategy, which is a novel system of studying the obese patient at the first visit, performed in groups of patients, aimed to the collection and analysis of data in order to categorize phenotypic profiles which may achive homogeneous responses to a specific therapy. We also analyze the costs of this new strategy compared to those of an individual consultation, showing a decrease of 58% for the first visit, and of 21% of the total costs throughout treatment.
Vázquez
C
C
Unidad de Nutrición Clínica y Dietética, Hospital Ramón y Cajal Madrid, España.
Alcaraz
F
F
Botella-Carretero
J I
JI
Zamarrón
I
I
Balsa
J
J
Arrieta
F
F
Carabaña
F
F
Garriga
M
M
Montagna
C
C
Secos
J
J
Barreales
P
P
Martínez
C
C
de la Cruz
P
P
D000328:Adult; D003365:Costs and Cost Analysis; D017048:Health Care Costs; D006801:Humans; D008875:Middle Aged; D009765:Obesity / Q000191:economics / Q000628:therapy*; D009819:Office Visits / Q000191:economics*; D015397:Program Evaluation; D012017:Referral and Consultation / Q000191:economics / Q000458:organization & administration